IRIS Signs New Three-Year Supply Agreement with Premier, a Healthcare Alliance Representing 2,300 Hospitals
12 juil. 2010 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., July 12, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial...
IRIS Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
06 juil. 2010 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., July 6, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial...
IRIS International Submits 510(k) Application to FDA for iChem(R)VELOCITY(TM) Automated Urine Chemistry Analyzer and iRICELL(R) Urinalysis Workstation
01 juil. 2010 07h14 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., July 1, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS to Host Financial Analyst and Investor Meeting at American Association for Clinical Chemistry (AACC) 2010 Annual Meeting & Clinical Lab Expo in Anaheim on July 28th
21 juin 2010 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., June 21, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals...
IRIS to Present at Jefferies 2010 Global Life Sciences Conference on June 10, 2010
25 mai 2010 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 25, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS to Participate at the 7th Annual Craig-Hallum Institutional Investor Conference June 2, 2010
20 mai 2010 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 20, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International Outlines Major Initiatives for 2010 and Beyond, With New Product Pipeline to Begin Generating Revenue and Earnings; Five New Product Releases Planned in 2010, and Development of Next Generation 3GEMS(TM) Program to Accelerate, Annual Meeting Told
18 mai 2010 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 18, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International Corporate Vice President and CFO Peter L. Donato Resigns
12 mai 2010 16h43 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 12, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International Reports Record First Quarter Revenue Spurred by Strong IVD Instrument Sales and Record Consumables and Service Revenue
03 mai 2010 16h01 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 3, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), reflecting continued improved instruments sales and record sales of consumables and service, today announced...
IRIS International Submits 510(k) Application to FDA for NADiA(R) ProsVue(TM) for Identifying Post-Prostatectomy Patients With Low Risk of Prostate Cancer Recurrence
29 avr. 2010 09h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., April 29, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...